Literature DB >> 33765086

Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection.

Morgane Rolland1,2,3, Peter B Gilbert4,5.   

Abstract

Entities:  

Year:  2021        PMID: 33765086      PMCID: PMC7993616          DOI: 10.1371/journal.ppat.1009406

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


× No keyword cloud information.
  18 in total

1.  Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.

Authors:  D E Neafsey; M Juraska; T Bedford; D Benkeser; C Valim; A Griggs; M Lievens; S Abdulla; S Adjei; T Agbenyega; S T Agnandji; P Aide; S Anderson; D Ansong; J J Aponte; K P Asante; P Bejon; A J Birkett; M Bruls; K M Connolly; U D'Alessandro; C Dobaño; S Gesase; B Greenwood; J Grimsby; H Tinto; M J Hamel; I Hoffman; P Kamthunzi; S Kariuki; P G Kremsner; A Leach; B Lell; N J Lennon; J Lusingu; K Marsh; F Martinson; J T Molel; E L Moss; P Njuguna; C F Ockenhouse; B Ragama Ogutu; W Otieno; L Otieno; K Otieno; S Owusu-Agyei; D J Park; K Pellé; D Robbins; C Russ; E M Ryan; J Sacarlal; B Sogoloff; H Sorgho; M Tanner; T Theander; I Valea; S K Volkman; Q Yu; D Lapierre; B W Birren; P B Gilbert; D F Wirth
Journal:  N Engl J Med       Date:  2015-10-21       Impact factor: 91.245

Review 2.  Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.

Authors:  Edward A Belongia; Melissa D Simpson; Jennifer P King; Maria E Sundaram; Nicholas S Kelley; Michael T Osterholm; Huong Q McLean
Journal:  Lancet Infect Dis       Date:  2016-04-06       Impact factor: 25.071

3.  Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.

Authors:  Ruanne V Barnabas; Elizabeth R Brown; Anna Bershteyn; Helen C Stankiewicz Karita; Christine Johnston; Lorna E Thorpe; Angelica Kottkamp; Kathleen M Neuzil; Miriam K Laufer; Meagan Deming; Michael K Paasche-Orlow; Patricia J Kissinger; Alfred Luk; Kristopher Paolino; Raphael J Landovitz; Risa Hoffman; Torin T Schaafsma; Meighan L Krows; Katherine K Thomas; Susan Morrison; Harald S Haugen; Lara Kidoguchi; Mark Wener; Alexander L Greninger; Meei-Li Huang; Keith R Jerome; Anna Wald; Connie Celum; Helen Y Chu; Jared M Baeten
Journal:  Ann Intern Med       Date:  2020-12-08       Impact factor: 25.391

4.  Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.

Authors:  Tyler N Starr; Allison J Greaney; Sarah K Hilton; Daniel Ellis; Katharine H D Crawford; Adam S Dingens; Mary Jane Navarro; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; Neil P King; David Veesler; Jesse D Bloom
Journal:  Cell       Date:  2020-08-11       Impact factor: 41.582

5.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.

Authors:  Morgane Rolland; Paul T Edlefsen; Brendan B Larsen; Sodsai Tovanabutra; Eric Sanders-Buell; Tomer Hertz; Allan C deCamp; Chris Carrico; Sergey Menis; Craig A Magaret; Hasan Ahmed; Michal Juraska; Lennie Chen; Philip Konopa; Snehal Nariya; Julia N Stoddard; Kim Wong; Hong Zhao; Wenjie Deng; Brandon S Maust; Meera Bose; Shana Howell; Adam Bates; Michelle Lazzaro; Annemarie O'Sullivan; Esther Lei; Andrea Bradfield; Grace Ibitamuno; Vatcharain Assawadarachai; Robert J O'Connell; Mark S deSouza; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Merlin L Robb; Jason S McLellan; Ivelin Georgiev; Peter D Kwong; Jonathan M Carlson; Nelson L Michael; William R Schief; Peter B Gilbert; James I Mullins; Jerome H Kim
Journal:  Nature       Date:  2012-09-10       Impact factor: 49.962

6.  Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.

Authors:  Alina Baum; Benjamin O Fulton; Elzbieta Wloga; Richard Copin; Kristen E Pascal; Vincenzo Russo; Stephanie Giordano; Kathryn Lanza; Nicole Negron; Min Ni; Yi Wei; Gurinder S Atwal; Andrew J Murphy; Neil Stahl; George D Yancopoulos; Christos A Kyratsous
Journal:  Science       Date:  2020-06-15       Impact factor: 47.728

7.  Temporal signal and the phylodynamic threshold of SARS-CoV-2.

Authors:  Sebastian Duchene; Leo Featherstone; Melina Haritopoulou-Sinanidou; Andrew Rambaut; Philippe Lemey; Guy Baele
Journal:  Virus Evol       Date:  2020-08-19

8.  Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.

Authors:  Victoria A Avanzato; M Jeremiah Matson; Stephanie N Seifert; Rhys Pryce; Brandi N Williamson; Sarah L Anzick; Kent Barbian; Seth D Judson; Elizabeth R Fischer; Craig Martens; Thomas A Bowden; Emmie de Wit; Francis X Riedo; Vincent J Munster
Journal:  Cell       Date:  2020-11-04       Impact factor: 41.582

9.  Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.

Authors:  Devan V Mehrotra; Holly E Janes; Thomas R Fleming; Paula W Annunziato; Kathleen M Neuzil; Lindsay N Carpp; David Benkeser; Elizabeth R Brown; Marco Carone; Iksung Cho; Deborah Donnell; Michael P Fay; Youyi Fong; Shu Han; Ian Hirsch; Ying Huang; Yunda Huang; Ollivier Hyrien; Michal Juraska; Alex Luedtke; Martha Nason; An Vandebosch; Honghong Zhou; Myron S Cohen; Lawrence Corey; Jonathan Hartzel; Dean Follmann; Peter B Gilbert
Journal:  Ann Intern Med       Date:  2020-10-22       Impact factor: 25.391

10.  A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.

Authors:  Bethany Dearlove; Eric Lewitus; Hongjun Bai; Yifan Li; Daniel B Reeves; M Gordon Joyce; Paul T Scott; Mihret F Amare; Sandhya Vasan; Nelson L Michael; Kayvon Modjarrad; Morgane Rolland
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 12.779

View more
  6 in total

Review 1.  COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective.

Authors:  Jasmine R Marcelin; Audrey Pettifor; Holly Janes; Elizabeth R Brown; James G Kublin; Kathryn E Stephenson
Journal:  Open Forum Infect Dis       Date:  2022-03-10       Impact factor: 4.423

Review 2.  Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection).

Authors:  Amy C Sherman; Michaël Desjardins; Lindsey R Baden
Journal:  Clin Lab Med       Date:  2021-11-03       Impact factor: 1.935

3.  Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses.

Authors:  Olga I Yarovaya; Dmitriy N Shcherbakov; Sophia S Borisevich; Anastasiya S Sokolova; Maxim A Gureev; Edward M Khamitov; Nadezda B Rudometova; Anastasiya V Zybkina; Ekaterina D Mordvinova; Anna V Zaykovskaya; Artem D Rogachev; Oleg V Pyankov; Rinat A Maksyutov; Nariman F Salakhutdinov
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

4.  Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance.

Authors:  Lirong Cao; Jingzhi Lou; See Yeung Chan; Hong Zheng; Caiqi Liu; Shi Zhao; Qi Li; Chris Ka Pun Mok; Renee Wan Yi Chan; Marc Ka Chun Chong; William Ka Kei Wu; Zigui Chen; Eliza Lai Yi Wong; Paul Kay Sheung Chan; Benny Chung Ying Zee; Eng Kiong Yeoh; Maggie Haitian Wang
Journal:  Nat Med       Date:  2022-06-16       Impact factor: 87.241

5.  Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020-March 2021) Using a Statistical Learning Strategy.

Authors:  Lue Ping Zhao; Terry P Lybrand; Peter B Gilbert; Thomas R Hawn; Joshua T Schiffer; Leonidas Stamatatos; Thomas H Payne; Lindsay N Carpp; Daniel E Geraghty; Keith R Jerome
Journal:  Viruses       Date:  2021-12-21       Impact factor: 5.818

6.  Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 - 2021/03) Using a Statistical Learning Strategy.

Authors:  Lue Ping Zhao; Terry P Lybrand; Peter B Gilbert; Thomas R Hawn; Joshua T Schiffer; Leonidas Stamatatos; Thomas H Payne; Lindsay N Carpp; Daniel E Geraghty; Keith R Jerome
Journal:  bioRxiv       Date:  2021-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.